Bacterial Endotoxin Testing by LAL

Article

GMP/GLP compliant testing laboratory, Wickham Laboratories Ltd, offers a dedicated in vitro bacterial endotoxin service for clients requiring biocompatibility testing.

 

 

Wickham Laboratories offers biocompatibility assessment via the Limulus Amebocyte Lysate (LAL) method to those of our clients requiring bacterial endotoxin screening. With over 20 years of experience in bacterial endotoxin testing, we are uniquely equipped to deal with your challenging and complicated samples, including cytotoxics.


LAL is an established in vitro test for the screening of parenteral medicines, irrigation fluids, dialysis solutions, purified water and medical devices. We offer all three standard LAL methods: gel clot, kinetic chromogenic and kinetic turbidimetric, working closely with our clients to determine which method is best for their particular requirements.


As a GMP/GLP compliant laboratory with over 50 years of experience, we are an established name in the fields of pharmaceutical and medical device contract testing, research and consultancy. We are routinely inspected by the MHRA, FDA and Home Office and maintain an audit ready facility at all times.


Conducting business with clients worldwide, the combined expertise of our laboratory technicians and managers enables us to be fully conversant with global regulatory expectations. For more information about Wickham Laboratories Limited and our services, please contact us at +44 (0)1329 226600 or mail@wickhamlabs.co.uk.

 

Contact Details:
Wickham Laboratories Ltd
Website: www.wickhamlabs.co.uk
E-mail: mail@wickhamlabs.co.uk

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content